The U.S. health regulator said on Wednesday that it is working to address a shortage of a particular form of albuterol, a medication used to treat breathing conditions, as its sole manufacturer Akorn has stopped production.
https://www.pharmalive.com/wp-content/uploads/2022/05/ReutersFDAlogo5-23-2022.webp7401200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-03-08 21:28:142023-03-09 10:40:18U.S. FDA flags shortage of medication used to treat breathing conditions
